...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: How is Zenith affected by the RVX top line miss

Would like to know if Zenith is affected by this miss? I’ve been of the opinion that the Zenith story is a totally separate issue here. Anyone care to comment on this?

Share
New Message
Please login to post a reply